By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


SEARCH JOBS



Segment
Drug Discovery





Company News
Can-Fite BioPharma (CFBI) Reports Financial Results For Nine Months Ended September 30, 2016 & Provides Clinical Update 11/28/2016 7:57:00 AM
American Medical Association's USAN & WHO's INN Approve "Namodenoson" As Generic Name For Can-Fite BioPharma (CFBI)'s Liver Drug CF102 11/16/2016 8:31:39 AM
Can-Fite BioPharma (CFBI) Receives Notice Of Allowance From U.S. Patent And Trademark Office For Erectile Dysfunction Drug 11/10/2016 2:54:53 PM
Can-Fite BioPharma (CFBI) Advances Towards A Pivotal Phase III Clinical Trial In Psoriasis With Piclidenoson (CF101) Following Reaching Agreement With EMA 11/1/2016 6:37:20 AM
Can-Fite BioPharma (CFBI) Signs Distribution Deal For Liver Cancer Drug CF102 In South Korea 10/25/2016 7:03:25 AM
Can-Fite BioPharma (CFBI) Submits Protocol for Phase II Trial of CF102 in the Treatment of NAFLD/NASH 10/13/2016 6:58:51 AM
Can-Fite BioPharma (CFBI) Reports New Data On CF102's Liver Protective & Regenerative Properties Published In Scientific Journal 9/20/2016 9:04:15 AM
Can-Fite BioPharma (CFBI) Receives Notice Of Allowance For Psoriasis Patent In Europe Ahead Of Phase III Trial 9/13/2016 6:42:17 AM
Can-Fite BioPharma (CFBI) To Present At Rodman & Renshaw Conference In New York City On September 12, 2016 9/7/2016 10:41:02 AM
Can-Fite BioPharma (CFBI) Reports Financial Results For Six Months Ended June 30, 2016 8/26/2016 9:55:19 AM
12345678910...
//-->